Medical XpressCancer immunotherapy may get a boost by disabling specific T cellsMedical XpressCancer immunotherapy drugs only work for a minority of patients, but a generic drug now used to increase blood flow may be able to improve those odds, … Continue reading
The San Diego Union-TribuneImmunotherapy combination safe and 62 percent effective in metastatic melanoma patientsMedical XpressImmunotherapy is a promising approach in the treatment of metastatic melanoma, an aggressive and deadly form of skin cancer… Continue reading
Anti Aging News |
Stem Cell Factor Tied to Reduced Risk of Cardiac Events, Death
Anti Aging News (HealthDay News) — High levels of stem cell factor (SCF) are associated with reduced risk of mortality and cardiovascular events, according to a study published online Aug. 26 in the Journal of Internal Medicine. Harry Björkbacka, Ph.D., from Lund … |
FierceBiotech |
GlaxoSmithKline hits ‘go’ on Adaptimmune’s SPEAR T–cell program
FierceBiotech As CAR-T and T–cell therapies continue to make headlines, GlaxoSmithKline has taken up the option to work on Adaptimmune’s T–cell therapy. GSK has been shaking up its R&D following the arrival of new CEO Emma Walmsley, including potentially … |
|
Barclays Begins Coverage on Editas Medicine, Inc. (EDIT) With An …
Finance Daily On July 18, 2017 Oppenheimer starting coverage on EDIT by announcing an initial rating of “Perform”. SunTrust Robinson Humphrey started covering EDIT … |